pSivida Announces FDA Acceptance For Filing of New Drug Application for Durasert Pharmaceutical Investing
Cellectar Biosciences Granted Orphan Drug Designation for CLR 131 to Treat Neuroblastoma Pharmaceutical Investing
Aclaris Therapeutics Announces Positive Update on Phase 2 Results after a 3-month Follow-Up Pharmaceutical Investing
Dova Pharmaceuticals Signs Exclusive Distribution Agreement with Fosun Pharma For Mainland China and Hong Kong Pharmaceutical Investing
Denali Therapeutics Announces Reports Full Year 2017 Financial Results And Business Highlights Pharmaceutical Investing
